Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells

Journal of Virology

Volumn 87, Issue 19, 2013, Pages 10828-10842

  Glauser, Daniel L ^a,b   Milho, Ricardo ^a   Frederico, Bruno ^a   May, Janet S ^a   Kratz, Anne Sophie ^a,c   Gillet, Laurent ^a,d   Stevenson, Philip G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN B;

ANIMAL CELL; ANTIGENICITY; ARTICLE; BONE MARROW CELL; DEGLYCOSYLATION; DENDRITIC CELL; ENDOCYTOSIS; EPITHELIUM CELL; FEMALE; FIBROBLAST; GLYCOSYLATION; HERPES SIMPLEX VIRUS; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MOUSE; MURID HERPES VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN FUNCTION; VIRION; VIRUS ENTRY; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TITRATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FURIN; GLYCOPROTEINS; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTATION; MYELOID CELLS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHADINOVIRUS; RNA, MESSENGER; SEQUENCE HOMOLOGY, NUCLEIC ACID; VIRAL ENVELOPE PROTEINS; VIRION; VIRUS REPLICATION;

EID: 84886033246     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00709-13     Document Type: Article

References (54)

1. Heldwein EE, Krummenacher C. 2008. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 65:1653-1668.
2. Backovic M, Jardetzky TS. 2009. Class III viral membrane fusion proteins. Curr. Opin. Struct. Biol. 19:189-196.
3. Backovic M, Longnecker R, Jardetzky TS. 2009. Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B. Proc. Natl. Acad. Sci. U.S.A. 106:2880-2885.
4. Heldwein EE, Lou H, Bender FC, Cohen GH, Eisenberg RJ, Harrison SC. 2006. Crystal structure of glycoprotein B from herpes simplex virus 1. Science 313:217-220.
5. Kadlec J, Loureiro S, Abrescia NG, Stuart DI, Jones IM. 2008. The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines. Nat. Struct. Mol. Biol. 15:1024-1030.
6. Roche S, Bressanelli S, Rey FA, Gaudin Y. 2006. Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G. Science 313:187-191.
7. Roche S, Rey FA, Gaudin Y, Bressanelli S. 2007. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G. Science 315: 843-848.
8. Hosaka M, Nagahama M, Kim WS, Watanabe T, Hatsuzawa K, Ikemizu J, Murakami K, Nakayama K. 1991. Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway. J. Biol. Chem. 266:12127-12130.
9. Thomas G. 2002. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell Biol. 3:753-766.
10. Britt WJ, Vugler LG. 1989. Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J. Virol. 63:403-410.
11. Okazaki K. 2007. Proteolytic cleavage of glycoprotein B is dispensable for in vitro replication, but required for syncytium formation of pseudorabies virus. J. Gen. Virol. 88:1859-1865.
12. Kopp A, Blewett E, Misra V, Mettenleiter TC. 1994. Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus. J. Virol. 68:1667-1674.
13. Oliver SL, Sommer M, Zerboni L, Rajamani J, Grose C, Arvin AM. 2009. Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. J. Virol. 83:7495-7506.
14. Strive T, Borst E, Messerle M, Radsak K. 2002. Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture. J. Virol. 76:1252-1264.
15. Sorem J, Longnecker R. 2009. Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells. J. Gen. Virol. 90:591-595.
16. Virgin HW, Latreille P, Wamsley P, Hallsworth K, Weck KE, Dal Canto AJ, Speck SH. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
17. Barton E, Mandal P, Speck SH. 2011. Pathogenesis and host control of gammaherpesviruses: lessons from the mouse. Annu. Rev. Immunol. 29: 351-397.
18. Stevenson PG, Simas JP, Efstathiou S. 2009. Immune control of mammalian gamma-herpesviruses: lessons from murid herpesvirus-4. J. Gen. Virol. 90:2317-2330.
19. Gaspar M, May JS, Sukla S, Frederico B, Gill MB, Smith CM, Belz GT, Stevenson PG. 2011. Murid herpesvirus-4 exploits dendritic cells to infect B cells. PLoS Pathog. 7:e1002346. doi:10.1371/journal.ppat.1002346.
20. Milho R, Smith CM, Marques S, Alenquer M, May JS, Gillet L, Gaspar M, Efstathiou S, Simas JP, Stevenson PG. 2009. In vivo imaging of murid herpesvirus-4 infection. J. Gen. Virol. 90:21-32.
21. Sunil-Chandra NP, Efstathiou S, Arno J, Nash AA. 1992. Virological and pathological features of mice infected with murine gamma-herpesvirus 68. J. Gen. Virol. 73:2347-2356.
22. Brooks JW, Hamilton-Easton AM, Christensen JP, Cardin RD, Hardy CL, Doherty PC. 1999. Requirement for CD40 ligand, CD4(+) T cells, and B cells in an infectious mononucleosis-like syndrome. J. Virol. 73: 9650-9654.
23. Evans AG, Moser JM, Krug LT, Pozharskaya V, Mora AL, Speck SH. 2008. A gammaherpesvirus-secreted activator of Vbeta4+ CD8+ T cells regulates chronic infection and immunopathology. J. Exp. Med. 205:669-684.
24. Stevenson PG, Doherty PC. 1999. Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. J. Virol. 73:1075-1079.
25. Usherwood EJ, Ross AJ, Allen DJ, Nash AA. 1996. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J. Gen. Virol. 77:627-630.
26. Glauser DL, Kratz AS, Gillet L, Stevenson PG. 2011. A mechanistic basis for potent, glycoprotein B-directed gammaherpesvirus neutralization. J. Gen. Virol. 92:2020-2033.
27. Lopes FB, Colaco S, May JS, Stevenson PG. 2004. Characterization of murine gammaherpesvirus 68 glycoprotein B. J. Virol. 78:13370-13375.
28. Mettenleiter TC, Klupp BG, Granzow H. 2006. Herpesvirus assembly: a tale of two membranes. Curr. Opin. Microbiol. 9:423-429.
29. Adler H, Messerle M, Wagner M, Koszinowski UH. 2000. Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome. J. Virol. 74:6964-6974.
30. Messerle M, Crnkovic I, Hammerschmidt W, Ziegler H, Koszinowski UH. 1997. Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U.S.A. 94: 14759-14763.
31. de Lima BD, May JS, Stevenson PG. 2004. Murine gammaherpesvirus 68 lacking gp150 shows defective virion release but establishes normal latency in vivo. J. Virol. 78:5103-5112.
32. Gillet L, Gill MB, Colaco S, Smith CM, Stevenson PG. 2006. Murine gammaherpesvirus-68 glycoprotein B presents a difficult neutralization target to monoclonal antibodies derived from infected mice. J. Gen. Virol. 87:3515-3527.
33. Gillet L, Colaco S, Stevenson PG. 2008. Glycoprotein B switches conformation during murid herpesvirus 4 entry. J. Gen. Virol. 89:1352-1363.
34. May JS, Colaco S, Stevenson PG. 2005. Glycoprotein M is an essential lytic replication protein of the murine gammaherpesvirus 68. J. Virol. 79:3459-3467.
35. Gill MB, Gillet L, Colaco S, May JS, de Lima BD, Stevenson PG. 2006. Murine gammaherpesvirus-68 glycoprotein H-glycoprotein L complex is a major target for neutralizing monoclonal antibodies. J. Gen. Virol. 87: 1465-1475.
36. Glauser DL, Kratz AS, Stevenson PG. 2012. Herpesvirus glycoproteins undergo multiple antigenic changes before membrane fusion. PLoS One 7:e30152. doi:10.1371/journal.pone.0030152.
37. Roy A, Kucukural A, Zhang Y. 2010. I-TASSER: a unified platform for automated protein structure and function prediction. Nat. Protoc. 5:725-738.
38. Zhang Y. 2008. I-TASSER server for protein 3D structure prediction. BMC Bioinformatics 9:40. doi:10.1186/1471-2105-9-40.
39. Glauser DL, Strasser R, Laimbacher AS, Saydam O, Clément N, Linden RM, Ackermann M, Fraefel C. 2007. Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: molecular mechanisms of interaction. J. Virol. 81:4732-4743.
40. Efstathiou S, Ho YM, Minson AC. 1990. Cloning and molecular characterization of the murine herpesvirus 68 genome. J. Gen. Virol. 71:1355-1364.
41. Frederico B, Milho R, May JS, Gillet L, Stevenson PG. 2012. Myeloid infection links epithelial and B cell tropisms of murid herpesvirus-4. PLoS Pathog. 8:e1002935. doi:10.1371/journal.ppat.1002935.
42. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA. 2000. Latent murine gamma-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J. Immunol. 165:1074-1081.
43. Sunil-Chandra NP, Efstathiou S, Nash AA. 1992. Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. J. Gen. Virol. 73:3275-3279.
44. Rosa GT, Gillet L, Smith CM, de Lima BD, Stevenson PG. 2007. IgG fc receptors provide an alternative infection route for murine gammaherpesvirus-68. PLoS One 2:e560. doi:10.1371/journal.pone.0000560.
45. Glauser DL, Gillet L, Stevenson PG. 2012. Virion endocytosis is a major target for murid herpesvirus-4 neutralization. J. Gen. Virol. 93:1316-1327.
46. Gillet L, Stevenson PG. 2007. Evidence for a multiprotein gamma-2 herpesvirus entry complex. J. Virol. 81:13082-13091.
47. Gillet L, Alenquer M, Glauser DL, Colaco S, May JS, Stevenson PG. 2009. Glycoprotein L sets the neutralization profile of murid herpesvirus 4. J. Gen. Virol. 90:1202-1214.
48. Guth AM, Janssen WJ, Bosio CM, Crouch EC, Henson PM, Dow SW. 2009. Lung environment determines unique phenotype of alveolar macrophages. Am. J. Physiol. Lung Cell. Mol. Physiol. 296:L936-L946. doi:10 .1152/ajplung.90625.2008.
49. Song L, Lee C, Schindler C. 2011. Deletion of the murine scavenger receptor CD68. J. Lipid Res. 52:1542-1550.
50. Zheng D, Limmon GV, Yin L, Leung NH, Yu H, Chow VT, Chen J. 2012. Regeneration of alveolar type I and II cells from Scgb1a1-expressing cells following severe pulmonary damage induced by bleomycin and influenza. PLoS One 7:e48451. doi:10.1371/journal.pone.0048451.
51. Stevenson PG, Belz GT, Castrucci MR, Altman JD, Doherty PC. 1999. Agamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope. Proc. Natl. Acad. Sci. U.S.A. 96:9281-9286.
52. Tibbetts SA, Loh J, Van Berkel V, McClellan JS, Jacoby MA, Kapadia SB, Speck SH, Virgin HW. 2003. Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection. J. Virol. 77:7696-7701.
53. Flano E, Jia Q, Moore J, Woodland DL, Sun R, Blackman MA. 2005. Early establishment of gamma-herpesvirus latency: implications for immune control. J. Immunol. 174:4972-4978.
54. Gillet L, Colaco S, Stevenson PG. 2008. The murid herpesvirus-4 gL regulates an entry-associated conformation change in gH. PLoS One 3:e2811. doi:10.1371/journal.pone.0002811.